Market Overview:
The global Temporary Total Artificial Heart (TAH) market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of heart diseases, technological advancements in TAH devices, and rising demand for TAH devices in emerging countries. The Temporary Total Artificial Heart (TAH) market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into SynCardia Systems and others. On the basis of application, the market is segmented into dilated cardiomyopathy, ischemic cardiomyopathy, and others. The North America region dominates the global Temporary Total Artificial Heart (TAH) market followed by Europe and Asia Pacific regions respectively.
Product Definition:
A Temporary Total Artificial Heart (TAH) is a surgically implanted device that helps to pump blood throughout the body. It is typically used as a temporary measure while a patient awaits a heart transplant. The TAH can keep patients alive for weeks or even months, until they can receive a new heart.
SynCardia Systems:
SynCardia is a Synchronized Cardiac Rhythm Management Device (SCRAM) used in TAH. It is the first and only FDA approved SCRAM device for patients with end-stage heart failure. The FDA approval of this product has changed the scenario of TAH devices market as it has created huge opportunities for manufacturers to develop their products which are expected to be launched over the forecast period.
Others:
Others are the accessories that are used in TAH and it includes all the devices, which are not classified as pumps & circuits or catheters. The Others segment is expected to grow at a CAGR of XX% during forecast period 2016-2021 due to increasing number of product approvals by FDA for TAH and growing awareness among patients regarding its benefits.
The temporary total artificial heart (TAH) market is segmented into two parts namely products.
Application Insights:
The others segment held the largest share of the global market in 2017. This is due to high unmet clinical needs and high adoption of these devices for treating various heart diseases such as arrhythmia, heart failure, and stroke.
Dilated cardiomyopathy (DCM) accounted for a significant share in 2017 due largely to increasing prevalence of dilated cardiomyopathy across all age groups globally. According this study conducted by National Center For Biotechnology Information (NCBI), it was found that around 1:5 adults aged more than 60 years suffer from DCM while about 1:10 children below five years have mitral regurgitation or stenosis which may require surgery in near future.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to favorable government initiatives, high disposable income, and availability of highly skilled physicians. Moreover, increasing demand for minimally invasive surgeries is also expected to drive the regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising patient awareness levels regarding TAHs and growing medical tourism industry in this region. Furthermore, rapidly improving healthcare infrastructure along with supportive government policies are some factors that can be attributed for rapid development of Cardiac Surgery Devices Market in this region over past few years.
Growth Factors:
- Increasing incidence of heart failure: The global incidence of heart failure is expected to increase from 26 million in 2016 to 39 million by 2025, owing to the aging population and rising prevalence of risk factors such as obesity and diabetes. This will create a large pool of patients who will require TAHs for treatment.
- Growing demand for minimally invasive procedures: TAH implantation is a minimally invasive procedure that can be performed through small incisions, which reduces the patient’s recovery time and hospital stay. This growing demand for minimally invasive procedures will boost the growth of the TAH market.
- Technological advancements: The development of novel technologies such as ventricular assist devices (VADs) that can support both left and right ventricles has led to increased adoption rates of TAHs, thereby driving market growth. Additionally, advances in materials science are resulting in the development of lighter and smaller TAH implants that are easier to implant and cause less damage to surrounding tissues.
Scope Of The Report
Report Attributes
Report Details
Report Title
Temporary Total Artificial Heart (TAH) Market Research Report
By Type
SynCardia Systems, Others
By Application
Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Others
By Companies
SynCardia, BiVACOR, CARMAT, ReinHeart TAH GmbH, Cleveland Heart, AbioMed, OregonHeart, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Temporary Total Artificial Heart (TAH) Market Report Segments:
The global Temporary Total Artificial Heart (TAH) market is segmented on the basis of:
Types
SynCardia Systems, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SynCardia
- BiVACOR
- CARMAT
- ReinHeart TAH GmbH
- Cleveland Heart
- AbioMed
- OregonHeart, Inc.
Highlights of The Temporary Total Artificial Heart (TAH) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- SynCardia Systems
- Others
- By Application:
- Dilated Cardiomyopathy
- Ischemic Cardiomyopathy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Temporary Total Artificial Heart (TAH) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Temporary Total Artificial Heart (TAH) is a device that helps patients with heart failure live longer. A TAH replaces part of the heart and helps the patient to keep their blood flowing.
Some of the major companies in the temporary total artificial heart (tah) market are SynCardia, BiVACOR, CARMAT, ReinHeart TAH GmbH, Cleveland Heart, AbioMed, OregonHeart, Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Temporary Total Artificial Heart (TAH) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Temporary Total Artificial Heart (TAH) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Temporary Total Artificial Heart (TAH) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Temporary Total Artificial Heart (TAH) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Temporary Total Artificial Heart (TAH) Market Size & Forecast, 2020-2028 4.5.1 Temporary Total Artificial Heart (TAH) Market Size and Y-o-Y Growth 4.5.2 Temporary Total Artificial Heart (TAH) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 SynCardia Systems
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Dilated Cardiomyopathy
6.2.2 Ischemic Cardiomyopathy
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Temporary Total Artificial Heart (TAH) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Temporary Total Artificial Heart (TAH) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 SynCardia Systems
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Dilated Cardiomyopathy
9.10.2 Ischemic Cardiomyopathy
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 SynCardia Systems
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Dilated Cardiomyopathy
10.10.2 Ischemic Cardiomyopathy
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 SynCardia Systems
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Dilated Cardiomyopathy
11.10.2 Ischemic Cardiomyopathy
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 SynCardia Systems
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Dilated Cardiomyopathy
12.10.2 Ischemic Cardiomyopathy
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 SynCardia Systems
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Dilated Cardiomyopathy
13.10.2 Ischemic Cardiomyopathy
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Temporary Total Artificial Heart (TAH) Market: Competitive Dashboard
14.2 Global Temporary Total Artificial Heart (TAH) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SynCardia
14.3.2 BiVACOR
14.3.3 CARMAT
14.3.4 ReinHeart TAH GmbH
14.3.5 Cleveland Heart
14.3.6 AbioMed
14.3.7 OregonHeart, Inc.